BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24747530)

  • 1. Production of iodine-124 and its applications in nuclear medicine.
    Braghirolli AM; Waissmann W; da Silva JB; dos Santos GR
    Appl Radiat Isot; 2014 Aug; 90():138-48. PubMed ID: 24747530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (124)I in PET imaging: impact on quantification, radiopharmaceutical development and distribution.
    Bockisch A; Freudenberg L; Rosenbaum S; Jentzen W
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1247-8. PubMed ID: 16909225
    [No Abstract]   [Full Text] [Related]  

  • 3. Three-dimensional positron emission tomography imaging with 124I and 86Y.
    Vandenberghe S
    Nucl Med Commun; 2006 Mar; 27(3):237-45. PubMed ID: 16479243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triaryl (Z)-olefins suitable for radiolabeling with iodine-124 or fluorine-18 radionuclides for positron emission tomography imaging of estrogen positive breast tumors.
    Abdellatif KR; Velázquez CA; Huang Z; Chowdhury MA; Knaus EE
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1195-8. PubMed ID: 21237640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124.
    Herzog H; Tellmann L; Scholten B; Coenen HH; Qaim SM
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):159-65. PubMed ID: 18043538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiochemical synthesis of 2'-[18F]-labelled and 3'-[18F]-labelled nucleosides for positron emission tomography imaging.
    Meyer JP; Probst KC; Westwell AD
    J Labelled Comp Radiopharm; 2014 May; 57(5):333-7. PubMed ID: 24692121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-124: a promising positron emitter for organic PET chemistry.
    Koehler L; Gagnon K; McQuarrie S; Wuest F
    Molecules; 2010 Apr; 15(4):2686-718. PubMed ID: 20428073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image quality with non-standard nuclides in PET.
    Laforest R; Liu X
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):151-8. PubMed ID: 18043539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative imaging of iodine-124 with PET.
    Pentlow KS; Graham MC; Lambrecht RM; Daghighian F; Bacharach SL; Bendriem B; Finn RD; Jordan K; Kalaigian H; Karp JS; Robeson WR; Larson SM
    J Nucl Med; 1996 Sep; 37(9):1557-62. PubMed ID: 8790218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The next generation of positron emission tomography radiopharmaceuticals in oncology.
    Rice SL; Roney CA; Daumar P; Lewis JS
    Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production, processing and small animal PET imaging of titanium-45.
    Vāvere AL; Laforest R; Welch MJ
    Nucl Med Biol; 2005 Feb; 32(2):117-22. PubMed ID: 15721756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis of N-[(11)C]-methyl-hydroxyfasudil as a new potential PET radiotracer for rho-kinases (ROCKs).
    Valdivia AC; Mason S; Collins J; Buckley KR; Coletta P; Beanlands RS; Dasilva JN
    Appl Radiat Isot; 2010 Feb; 68(2):325-8. PubMed ID: 19939685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New horizons in cardiac innervation imaging: introduction of novel
    Kobayashi R; Chen X; Werner RA; Lapa C; Javadi MS; Higuchi T
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2302-2309. PubMed ID: 28905088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the short-lived non-pure positron-emitting nuclide (120)I for PET imaging.
    Herzog H; Qaim SM; Tellmann L; Spellerberg S; Kruecker D; Coenen HH
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1249-57. PubMed ID: 16845512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.
    Ruangma A; Bai B; Lewis JS; Sun X; Welch MJ; Leahy R; Laforest R
    Nucl Med Biol; 2006 Feb; 33(2):217-26. PubMed ID: 16546676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124.
    Kumar K; Ghosh A
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-standard PET radionuclides: time to get ready for new clinical PET strategies.
    Lucignani G
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):294-300. PubMed ID: 17187284
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of structurally identical fluorine-18 and iodine isotope labeling compounds for comparative imaging.
    Li Z; Ding YS; Gifford A; Fowler JS; Gatley JS
    Bioconjug Chem; 2003; 14(2):287-94. PubMed ID: 12643738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers.
    Cerqueira M; Case J; Maddahi J
    J Nucl Cardiol; 2015 Aug; 22(4):730-9. PubMed ID: 26129941
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in the production, processing and microPET image quality of technetium-94m.
    Bigott HM; Laforest R; Liu X; Ruangma A; Wuest F; Welch MJ
    Nucl Med Biol; 2006 Oct; 33(7):923-33. PubMed ID: 17045173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.